|
Can segmented regression with a fixed zero slope establish a true plateau?
|
|
0
|
56
|
October 13, 2026
|
|
Causal Formalism and RCTs
|
|
27
|
918
|
October 12, 2026
|
|
Glassy - Lightweight tooling for predictive multiplicity in linear regressions
|
|
0
|
50
|
October 12, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
90
|
5532
|
September 22, 2026
|
|
Sequel to the odds ratio story
|
|
14
|
429
|
September 11, 2026
|
|
Cobra effect and p values
|
|
10
|
412
|
September 10, 2026
|
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
10
|
3601
|
August 5, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
34
|
1220
|
June 21, 2026
|
|
Calculating the variance of mean event count in a vaccine study re-analysis
|
|
0
|
74
|
June 2, 2026
|
|
A Longitudinal Renal Health Outcome for Clinical Trials in Acute Kidney Injury?
|
|
15
|
356
|
May 22, 2026
|
|
Clustering & Synthetic data generating processes (SDPDs)
|
|
0
|
85
|
April 15, 2026
|
|
How can I communicate hazard ratios from log-transformed biomarkers in a clinically interpretable way?
|
|
4
|
249
|
April 3, 2026
|
|
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the 2 NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
|
|
2
|
149
|
December 11, 2025
|
|
Introduction to Forensic Metascience: Techniques to check the credibility of scientific reports
|
|
0
|
160
|
December 7, 2025
|
|
NEJM Trial - proportional hazard assumption
|
|
12
|
590
|
December 1, 2025
|
|
Omission of *absolute* risk reduction from NEJM Editorial on PSA testing
|
|
14
|
607
|
November 27, 2025
|
|
Rarity Roulette: A simulator for estimating hypothetical outcomes spreads for mass screenings
|
|
2
|
156
|
November 20, 2025
|
|
Individual response
|
|
266
|
50541
|
November 17, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
247
|
November 11, 2025
|
|
The rooster's crowing
|
|
0
|
149
|
October 20, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
843
|
October 9, 2025
|
|
Fine-Gray vs Cause-Specific Cox Regression
|
|
0
|
241
|
September 11, 2025
|
|
Table 2 Fallacy?: Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
|
|
32
|
4427
|
August 12, 2025
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
17
|
2507
|
August 4, 2025
|
|
Accounting for period effect in crossover studies with washout
|
|
0
|
89
|
July 2, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
303
|
May 8, 2025
|
|
Biobanks, data dredging and science-by-press-release
|
|
4
|
181
|
April 30, 2025
|
|
Lest we forget: “Epidemiology faces its limits”- 30 years later…
|
|
19
|
1561
|
April 3, 2025
|
|
Marginalizing predictions over categories of continuous predictors for lay audience presentations
|
|
5
|
512
|
January 28, 2025
|
|
Summary table of different Cox PHM models to compare them
|
|
7
|
1086
|
December 23, 2024
|